NCP Cross
机构: University of Southampton
每年引用次数
引用次数
引用: 54,018
H-指数: 112
I10-指数 : 373
出版物: 859
The certification of the copy number concentration of solutions of plasmid DNA containing a BCR-ABL b3a2 transcript fragment: ERM-AD623a, ERM-AD623b, ERM-AD623c, ERM-AD623d, ERM-AD623e, ERM-AD623f
Trapmann Stefanie , Emons Hendrik , Corbisier Philippe , Mazoua Stephane
Publications Office of the European Union
1
2012
Improved detection and molecular monitoring of FIP1L1-PDGFRA by analysis of patient-specific genomic DNA fusion junctions
FH Grand , D Grimwade , CE Hidalgo-Curtis , J Jovanovic
Haematologica 93 168 -168
2008
Defining low and undetectable levels of disease in CML: progress towards
S Akiki , G Gerrard , L Foroni , G Nickless
BRITISH JOURNAL OF HAEMATOLOGY , 161 pp. 63-64. (2013)
2013
COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
E Papaemmanuil , E Hellstrom-Lindberg , A Pellagatti , H Dolatshad
Haematologica 99 234 -234
2014
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
Rodica Talmaci , Andreas Hochhaus , Gareth Gerrard , Simona Soverini
Journal of Cancer Research and Clinical Oncology 1 -9
9
2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations.
William Shomali , Johannes Lübke , Lukas Reiter , Vito Dangelo
British Journal of Haematology
10
2021
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst , Andrew J Chase , Joannah Score , Claire E Hidalgo-Curtis
Nature Genetics 42 ( 8) 722 -726
930
2010
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
José L Vizmanos , Roberto Hernández , María J Vidal , María J Larráyoz
Hematology Journal 5 ( 6) 534 -537
61
2004
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
Amy V Jones , Andrew Chase , Richard T Silver , David Oscier
Nature Genetics 41 ( 4) 446 -449
304
2009
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Rocco Piazza , Simona Valletta , Nils Winkelmann , Sara Redaelli
Nature Genetics 45 ( 1) 18 -24
264
2013
Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
Lars A Forsberg , Chiara Rasi , Niklas Malmqvist , Hanna Davies
Nature Genetics 46 ( 6) 624 -628
202
2014
Paucimorphic alleles versus polymorphic alleles and rare mutations in disease causation: Theory, observation and detection
Ian NM Day , Khalid K Alharbi , Matt Smith , Mohammed A Aldahmesh
Current Genomics 5 ( 5) 431 -438
11
2004
RT-PCR studies in patients with chronic myeloid leukemia (CML) in remission 5 years after allogeneic stem cell transplant (SCT) define risk of subsequent relapse
R. M. Szydlo , J. F. Apperley , N. C.P. Cross , C. Craddock
Blood 96
2000
Decrease in JAK2V617F Allele Burden is Not a Prerequisite to Clinical Response in Patients with Polycythemia Vera (PV).
Richard T. Silver , Katherine Vandris , Joshua J. Goldman , Fernando Adriano
Blood 114 ( 22) 1908 -1908
2
2009
Diagnostic and therapeutic management of eosinophilia-associated chronic myeloproliferative disorders
A. Reiter , D. Grimwade , N. C.P. Cross
Haematologica 92 ( 9) 1153 -1158
15
2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β gene
C. Walz , G. Metzgeroth , C. Haferlach , A. Schmitt-Graeff
Haematologica 92 ( 2) 163 -169
76
2007
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis
A. V. Jones , N. C.P. Cross , H. E. White , A. R. Green
Haematologica 93 ( 10) 1560 -1564
51
2008
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case
L. Chiecchio , G. P. Dagrada , R. K.M. Protheroe , D. M. Stockley
Haematologica 94 ( 7) 1024 -1028
44
2009
Molecular basis of myelodysplastic/myeloproliferative neoplasms
A. Reiter , R. Invernizzi , N. C.P. Cross , M. Cazzola
Haematologica 94 ( 12) 1634 -1638
33
2009
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
L. Chiecchio , G. P. Dagrada , A. H. Ibrahim , E. Dachs Cabanas
Haematologica 94 ( 12) 1708 -1713
66
2009